Provided by Tiger Fintech (Singapore) Pte. Ltd.

IO Biotech, Inc.

1.50
-0.1050-6.56%
Volume:115.16K
Turnover:175.76K
Market Cap:98.49M
PE:-1.00
High:1.61
Open:1.61
Low:1.47
Close:1.60
Loading ...

Director Makes Bold Move with Major IO Biotech Stock Purchase

TIPRANKS
·
03 Jun

Heidi Hunter, Director, Reports Acquisition of IO Biotech Inc. Common Shares

Reuters
·
02 Jun

BRIEF-Io Biotech Inc Files For Resale Of Up To 5.6 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing

Reuters
·
24 May

IO Biotech files to sell 5.62M shares of common stock for holders

TIPRANKS
·
24 May

IO Biotech Inc Files for Resale of up to 5.6 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
24 May

Optimistic Outlook on IO Biotech: Promising Cancer Treatment Developments and Strategic Growth Moves

TIPRANKS
·
15 May

IO Biotech price target raised to $14 from $12 at H.C. Wainwright

TIPRANKS
·
15 May

IO Biotech Q1 EPS $(0.34) Beats $(0.38) Estimate

Benzinga
·
14 May

IO Biotech Reports Q1 2025 Net Loss of $22.4M, Up from $19.5M in Previous Year

Reuters
·
14 May

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

THOMSON REUTERS
·
14 May

IO Biotech Q1 Net Income USD -22.421 Million

THOMSON REUTERS
·
14 May

Press Release: IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

Dow Jones
·
14 May

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

GlobeNewswire
·
27 Apr

Piper Sandler Sticks to Their Buy Rating for IO Biotech (IOBT)

TIPRANKS
·
02 Apr

IO Biotech Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Apr

IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire
·
26 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Promising Clinical Developments and Delayed Data Boost IO Biotech’s Buy Rating

TIPRANKS
·
07 Mar

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
07 Mar

IO Biotech Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
05 Mar